Description
Fareston Tablets 60 mg. №30 Vial
Ingredients:
Each tablet contains 60 mg of toremifene citrate as the active ingredient.
Mechanism of Action:
Fareston, a selective estrogen receptor modulator (SERM), exerts its pharmacological effects by competitively inhibiting estrogen binding to estrogen receptors in breast tissue. This antiestrogenic action leads to the inhibition of estrogen-sensitive breast cancer cell growth.
Pharmacological Properties:
Fareston functions as an antiestrogen by blocking estrogen effects in breast tissue, thereby impeding the proliferation of cancer cells. Additionally, it may exhibit estrogen-like effects in other tissues, contributing to the maintenance of bone density and lipid profiles.
Indications for Use:
Fareston is indicated for the treatment of metastatic breast cancer in postmenopausal women. It is also prescribed to reduce the risk of breast cancer recurrence.
Contraindications:
Do not administer Fareston if there is a known hypersensitivity to toremifene or any tablet components. This medication is contraindicated in pregnant or lactating women.
Side Effects:
Common side effects of Fareston may include hot flashes and vaginal bleeding. It is essential to report any adverse reactions to your healthcare provider.
Usage Instructions:
The recommended dosage of Fareston is 60 mg (1 tablet) taken orally once daily, with or without food. Adhere strictly to the prescribed dosage regimen.
Benefits Compared to Analogues:
Fareston demonstrates comparable efficacy to other SERMs in treating breast cancer while boasting a more favorable side effect profile. Particularly, it may offer advantages for patients unresponsive to alternative hormonal therapies.
Suitable Patient Groups:
Fareston is suitable for postmenopausal women diagnosed with metastatic breast cancer or at risk of cancer recurrence. Consult a healthcare professional for individualized treatment recommendations.
Storage and Shelf Life:
Store Fareston tablets in a cool, dry place away from direct sunlight. Adhere to the expiry date indicated on the packaging to ensure medication potency.
Packaging Description:
Fareston tablets are supplied in a vial containing 30 tablets, with each tablet encapsulating 60 mg of toremifene citrate.
Clinical Evidence and Proven Effectiveness:
Fareston has demonstrated efficacy in treating breast cancer by inhibiting estrogen-sensitive cell growth. Research published in the Journal of Clinical Oncology has shown that toremifene improves progression-free survival in advanced breast cancer patients.
